Huang-Yu Yang (Chang Gung Memorial Hospital)

2007-2013 Doctor of Philosophy (Ph.D.)
Immunology Program, Johns Hopkins School of Medicine
Mentor: Drew Pardoll M.D., Ph.D

1991-1998 Doctor of Medicine (M.D.)
Taipei Medical University, Taipei, Taiwan

MicroRNA and Epigenetic Immune Regulation

Metabolic Nephropathy

Acute Kidney Injury (AKI)

Polycystic Kidney Disease (PKD)

Progression of Chronic Kidney Disease (Progression of CKD)

Cancer and Immunology

Chang HC, Tsai CY, Hsu CL, Tai TS, Cheng ML, Chuang YM, Tang HY, Lin KJ, Chen JJ, Chang SH, Ko YC, Chi YW, Liu H, Tan BC, Shen CR, Yang CW, Ho PC*, Yang HY*. Asparagine deprivation enhances T cell antitumour response in patients via ROS-mediated metabolic and signal adaptations. Nat Metab. 2025 May;7(5):918-927.

Chen JJ, Lee TH, Yang HY*. Exploring nontraditional cardiorenal advantages of SGLT-2 inhibitors and GLP-1 receptor agonists. Kidney Int. 2024 Mar;105(3):442-444.

Chen JJ, Wu CY, Jenq CC, Lee TH, Tsai CY, Tu HT, Huang YT, Yen CL, Yen TH, Chen YC, Tian YC, Yang CW, Yang HY*. Association of Glucagon-Like Peptide-1 Receptor Agonist vs Dipeptidyl Peptidase-4 Inhibitor Use With Mortality Among Patients With Type 2 Diabetes and Advanced Chronic Kidney Disease. JAMA Netw Open. 2022 Mar 1;5(3):e221169.

Yen CL, Wu CY, See LC, Li YJ, Tseng MH, Peng WS, Liu JR, Chen YC, Yen TH, Tian YC, Yang CW, Gerard F. Anderson, Yang HY*. Pioglitazone Reduces Mortality and Adverse Events in Patients with Type 2 Diabetes and with Advanced Chronic Kidney Disease: National Cohort Study. Diabetes Care.

Chen Z, Barbi J, Bu S, Yang HY, Li Z, Gao Y, Jinasena D, Fu J, Lin F, Chen C, Zhang J, Yu N, Li X, Shan Z, Nie J, Gao Z, Tian H, Li Y, Yao Z, Zheng Y, Park BV, Pan Z, Zhang J, Dang E, Li Z, Wang H, Luo W, Li L, Semenza GL, Zheng SG, Loser K, Tsun A, Greene MI, Pardoll DM, Pan F*, Li B*. The ubiquitin ligase stub1 negatively modulates regulatory T cell suppressive activity by promoting degradation of the transcription factor foxp3. Immunity.